1.
Vignal N, Kelly L, Lengline E, Cabannes-Hamy A, Siavellis J, Ghez D, Sauvageon H, Braun T, Jacqz-Aigrain E, Kohn M, Rousselot P, Puissant A, Raffoux E, Mourah S, Goldwirt L. Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia <i>FLT3</i&gt;-ITD patients. haematol [Internet]. 2023Sep.1 [cited 2024Jul.12];108(9):2531-4. Available from: https://haematologica.org/article/view/haematol.2022.282596